TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/26/2023
Back to search
Official data from USPTO
SYNER-G
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SYNER-G
ST13
US500000097030468Class
35, 42, 45
Filing
97030468
Registration
7198578
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
10/26/2023
Classification
Registered
Trademark type
Word
Nice classes
35, 42, 45
Filing date
09/16/2021
Registration date
10/24/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
10/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/15/2008
First use in commerce
10/09/2012
Drawing code
4
Owner type
16
Owner location
Framingham, MA
Examiner
GAYNOR, BARBARA
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SYNER-G BIOPHARMA GROUP LLC
SYNER-G BIOPHARMA GROUP LLC
Syner-G Pharma Consulting, LLC
Representatives
Sara M. Bauer Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
Class 42
Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials
Class 45
Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences
Publications
History of USPTO decisions and trademark events.
24 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/26/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/26/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/26/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/26/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/24/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2023
PUBO
PUBLISHED FOR OPPOSITION
08/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/05/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/03/2023
GNSL
LETTER OF SUSPENSION E-MAILED
01/03/2023
CNSL
SUSPENSION LETTER WRITTEN
01/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/22/2022
GNRT
NON-FINAL ACTION E-MAILED
06/22/2022
CNRT
NON-FINAL ACTION WRITTEN
06/22/2022
DOCK
ASSIGNED TO EXAMINER
06/21/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2021
NWAP
NEW APPLICATION ENTERED
09/20/2021
Continuous trademark protection
Get notified about every new filing that threatens SYNER-G or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.